tiprankstipranks
Trending News
More News >
BriaCell Therapeutics Corp (DE:8BT)
FRANKFURT:8BT
Germany Market

BriaCell Therapeutics (8BT) Financial Statements

Compare
0 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently C$16.56M. The company's EPS TTM is €-0.81; its P/E ratio is ―; BriaCell Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Jul 23Jul 22Jul 21
Income Statement
Total Revenue
Gross Profit----
Operating Income$ -33.33M$ -23.27M$ -15.29M$ -6.97M
EBITDA$ -4.59M$ -20.29M$ -27.10M$ -13.72M
Net Income$ -4.53M$ -20.30M$ -27.12M$ -13.82M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 5.87M$ 27.16M$ 42.58M$ 58.04M
Total Debt$ 0.00$ 0.00$ 0.00$ 25.99K
Net Debt$ -862.09K$ -21.25M$ -41.04M$ -57.24M
Total Liabilities$ 8.56M$ 30.94M$ 32.25M$ 30.37M
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -24.58M$ -23.74M$ -12.48M$ -7.75M
Operating Cash Flow$ -24.13M$ -23.74M$ -12.48M$ -7.75M
Investing Cash Flow
Financing Cash Flow
Currency in USD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis